Asymmetric dimethylarginine (ADMA) as a novel independent risk factor for cardiovascular disease in haemodialysis patients

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F07%3A00000219" target="_blank" >RIV/00216208:11140/07:00000219 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

čeština

Original language name

Asymmetric dimethylarginine (ADMA) as a novel independent risk factor for cardiovascular disease in haemodialysis patients

Original language description

Asymmetric dimethylarginine is independent of all other measured cardiovascular risk factors including homocysteine in hemodialysis patients.

Czech name

Asymmetric dimethylarginine (ADMA) as a novel independent risk factor for cardiovascular disease in haemodialysis patients

Czech description

Asymmetric dimethylarginine is independent of all other measured cardiovascular risk factors including homocysteine in hemodialysis patients.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FP - Other medical fields

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2007

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Klinická biochemie a metabolismus

ISSN

1210-7921

e-ISSN

—

Volume of the periodical

15

Issue of the periodical within the volume

1

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

4

Pages from-to

39-42

UT code for WoS article

—

EID of the result in the Scopus database

—